You are here

  • Home
  • Online First
  • Performance and risks of ChatGPT used in drug information: comment

Article Text

Article menu
Download PDFPDF
Letter
Performance and risks of ChatGPT used in drug information: comment
  1. Amnuay Kleebayoon1,
  2. Viroj Wiwanitkit2
  1. 1Private Academic Consultant, Samraong, Cambodia
  2. 2Research Center, Chandigarh University, Mohali, Punjab, India
  1. Correspondence to Dr Amnuay Kleebayoon, private academic consultant, samraong, Cambodia; amnuaykleebai{at}gmail.com

http://dx.doi.org/10.1136/ejhpharm-2023-003864

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest the article on ‘Performance and risks of ChatGPT used in drug information: an exploratory real-world analysis’.1 Morath et al consider the performance and risks of using Chat Generative Pre-trained Transformer (ChatGPT) to answer drug-related questions.1 In a real-world sample of 50 drug-related questions, Morath et al found that ChatGPT answered …

    View Full Text

    Footnotes

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.